22nd Century Total Non-Operating Income/Expense 2011-2025 | XXII
22nd Century total non-operating income/expense from 2011 to 2025. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
22nd Century Annual Total Non-Operating Income/Expense
(Millions of US $) |
| 2024 |
$-2 |
| 2023 |
$-10 |
| 2022 |
$-3 |
| 2021 |
$-4 |
| 2020 |
$0 |
| 2019 |
$-3 |
| 2018 |
$16 |
| 2017 |
$0 |
| 2016 |
$0 |
| 2015 |
$1 |
| 2014 |
$-4 |
| 2013 |
$-28 |
| 2012 |
$-3 |
| 2011 |
$2 |
| 2010 |
$0 |
22nd Century Quarterly Total Non-Operating Income/Expense
(Millions of US $) |
| 2025-03-31 |
$-1 |
| 2024-12-31 |
$0 |
| 2024-09-30 |
$0 |
| 2024-06-30 |
$0 |
| 2024-03-31 |
$-1 |
| 2023-12-31 |
$-8 |
| 2023-09-30 |
$0 |
| 2023-06-30 |
$-2 |
| 2023-03-31 |
$0 |
| 2022-12-31 |
$-1 |
| 2022-09-30 |
$0 |
| 2022-06-30 |
$-1 |
| 2022-03-31 |
$-1 |
| 2021-12-31 |
$-5 |
| 2021-09-30 |
$-2 |
| 2021-06-30 |
$2 |
| 2021-03-31 |
$0 |
| 2020-12-31 |
$0 |
| 2020-09-30 |
$0 |
| 2020-06-30 |
$0 |
| 2020-03-31 |
$0 |
| 2019-12-31 |
$-1 |
| 2019-09-30 |
$-3 |
| 2019-06-30 |
$-3 |
| 2019-03-31 |
$3 |
| 2018-12-31 |
$-3 |
| 2018-09-30 |
$13 |
| 2018-06-30 |
$0 |
| 2018-03-31 |
$6 |
| 2017-12-31 |
$0 |
| 2017-09-30 |
$0 |
| 2017-06-30 |
$0 |
| 2017-03-31 |
$0 |
| 2016-12-31 |
$0 |
| 2016-09-30 |
$0 |
| 2016-06-30 |
$0 |
| 2016-03-31 |
$0 |
| 2015-12-31 |
$0 |
| 2015-09-30 |
$0 |
| 2015-06-30 |
$1 |
| 2015-03-31 |
$0 |
| 2014-12-31 |
$0 |
| 2014-09-30 |
$0 |
| 2014-06-30 |
$0 |
| 2014-03-31 |
$-4 |
| 2013-12-31 |
$-14 |
| 2013-09-30 |
$-14 |
| 2013-06-30 |
$1 |
| 2013-03-31 |
$-1 |
| 2012-12-31 |
$-4 |
| 2012-09-30 |
$0 |
| 2012-06-30 |
$2 |
| 2012-03-31 |
$-2 |
| 2011-12-31 |
$2 |
| 2011-09-30 |
$0 |
| 2011-06-30 |
$0 |
| 2011-03-31 |
$0 |
| 2010-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Tobacco Products |
$0.001B |
$0.024B |
|
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
|
